Kraig Biocraft Laboratories (KBLB) Cash from Operations (2010 - 2025)

Kraig Biocraft Laboratories (KBLB) has 16 years of Cash from Operations data on file, last reported at 449487.0 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Operations rose 12.3% year-over-year to 449487.0; the trailing twelve-month figure through Dec 2025 stood at 1788970.0 (up 2.73% YoY), and the FY2025 full-year result was 1788970.0, up 2.73% from the prior year.
• Cash from Operations grew to 449487.0 in Q4 2025, from 461859.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 248718.0 in Q3 2023 to a low of 548152.0 in Q2 2021.
• A 5-year average of 428026.75 and a median of 442359.5 in 2022 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations jumped 48.77% in 2023 and sank 87.38% in 2024, its largest moves.
• Tracing KBLB's Cash from Operations over 5 years: stood at 395150.0 in 2021, then declined by 11.75% to 441594.0 in 2022, then grew by 25.79% to 327721.0 in 2023, then tumbled by 56.39% to 512523.0 in 2024, then grew by 12.3% to 449487.0 in 2025.
• Business Quant data shows KBLB's Cash from Operations at 449487.0 in Q4 2025, 461859.0 in Q3 2025, and 443125.0 in Q2 2025.